Showing results (1-10 of 266) with videos related to
Sort By:
Pageof 27
Pediatric Neurology|August 25, 2016
Fabry Disease: A Disorder of Childhood OnsetRaphael Schiffmann, Markus RiesMedicine|September 9, 2005
The relationship of vascular glycolipid storage to clinical manifestations of Fabry disease: a cross-sectional study of a large cohort of clinically affected heterozygous womenSurya Gupta, Markus Ries, Steven Kotsopoulos, et al.Pharmacoeconomics|March 6, 2007
Enzyme replacement therapy in orphan and ultra-orphan diseases: the limitations of standard economic metrics as exemplified by Fabry-Anderson diseaseDavid F Moore, Markus Ries, Evelyn L Forget, et al.Journal of Inherited Metabolic Disease|April 23, 2015
A prospective 10-year study of individualized, intensified enzyme replacement therapy in advanced Fabry diseaseRaphael Schiffmann, Caren Swift, Xuan Wang, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 6, 2005
Long-term therapy with agalsidase alfa for Fabry disease: safety and effects on renal function in a home infusion settingRaphael Schiffmann, Markus Ries, Margaret Timmons, et al.Virchows Archiv : an International Journal of Pathology|November 30, 2005
Pathological findings in a patient with Fabry disease who died after 2.5 years of enzyme replacementRaphael Schiffmann, Amy Rapkiewicz, Mones Abu-Asab, et al.Plos One|July 30, 2011
The saccadic and neurological deficits in type 3 Gaucher diseaseWilliam Benko, Markus Ries, Edythe A Wiggs, et al.Journal of the American Society of Nephrology : JASN|April 6, 2007
Weekly enzyme replacement therapy may slow decline of renal function in patients with Fabry disease who are on long-term biweekly dosingRaphael Schiffmann, Hasan Askari, Margaret Timmons, et al.Journal of Inherited Metabolic Disease|February 18, 2010
Therapeutic approaches for neuronopathic lysosomal storage disordersRaphael SchiffmannPageof 27